Liu Y - Search Results

1

Enhanced Sensitivity of Cancer Stem Cells to Chemotherapy Using Functionalized Mesoporous Silica Nanoparticles.

Chen Z, Zhu P, Zhang Y, Liu Y, He Y, Zhang L, Gao Y. Chen Z, et al. Among authors: liu y. Mol Pharm. 2016 Aug 1;13(8):2749-59. doi: 10.1021/acs.molpharmaceut.6b00352. Epub 2016 Jul 5. Mol Pharm. 2016. PMID: 27348602

2

Correction to "Enhanced Sensitivity of Cancer Stem Cells to Chemotherapy Using Functionalized Mesoporous Silica Nanoparticles".

Chen Z, Zhu P, Zhang Y, Liu Y, He Y, Zhang L, Gao Y. Chen Z, et al. Among authors: liu y. Mol Pharm. 2022 Nov 7;19(11):4390. doi: 10.1021/acs.molpharmaceut.2c00732. Epub 2022 Sep 15. Mol Pharm. 2022. PMID: 36108151 No abstract available.

3

LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.

Chen Z, Gao Y, Yao L, Liu Y, Huang L, Yan Z, Zhao W, Zhu P, Weng H. Chen Z, et al. Among authors: liu y. Oncogene. 2018 Jun;37(23):3098-3112. doi: 10.1038/s41388-018-0203-6. Epub 2018 Mar 14. Oncogene. 2018. PMID: 29535420 Free PMC article.

4

Withdrawal:The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1.

Chen Z, Liu Y, Yao L, Guo S, Gao Y, Zhu P. Chen Z, et al. Among authors: liu y. J Biol Chem. 2018 May 25;293(21):7982-7992. doi: 10.1074/jbc.RA117.001321. Epub 2018 Mar 27. J Biol Chem. 2018. PMID: 29588366 Free PMC article. Retracted.

5

LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis.

Chen Z, Yao L, Liu Y, Zhu P. Chen Z, et al. Among authors: liu y. Cancer Lett. 2018 Aug 28;430:88-96. doi: 10.1016/j.canlet.2018.05.023. Epub 2018 May 17. Cancer Lett. 2018. PMID: 29778568

6

Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.

Liu Y, Yao L, Cao W, Liu Y, Zhai W, Wu Y, Wang B, Gou S, Qin Y, Qi Y, Chen Z, Gao Y. Liu Y, et al. ACS Appl Bio Mater. 2019 Mar 18;2(3):1241-1254. doi: 10.1021/acsabm.8b00811. Epub 2019 Feb 18. ACS Appl Bio Mater. 2019. PMID: 35021373

7

Correction: LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.

Chen Z, Gao Y, Yao L, Liu Y, Huang L, Yan Z, Zhao W, Zhu P, Weng H. Chen Z, et al. Among authors: liu y. Oncogene. 2022 Aug;41(34):4115-4118. doi: 10.1038/s41388-022-02381-z. Oncogene. 2022. PMID: 35798879 Free PMC article. No abstract available.

8

Corrigendum to "LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis" [Cancer Lett. 430 (2018) 88-96].

Chen Z, Yao L, Liu Y, Zhu P. Chen Z, et al. Among authors: liu y. Cancer Lett. 2022 Oct 1;545:215835. doi: 10.1016/j.canlet.2022.215835. Epub 2022 Aug 9. Cancer Lett. 2022. PMID: 35961848 No abstract available.

9

Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M.

Liu J, Spence MJ, Zhang YL, Jiang Y, Liu YE, Shi YE. Liu J, et al. Among authors: liu ye. Breast Cancer Res Treat. 2000 Jul;62(2):99-107. doi: 10.1023/a:1006418219012. Breast Cancer Res Treat. 2000. PMID: 11016747

10

The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor.

Ouyang L, Yan B, Liu Y, Mao C, Wang M, Liu N, Wang Z, Liu S, Shi Y, Chen L, Wang X, Cheng Y, Cao Y, Xiao D, Zhang L, Liu S, Tao Y. Ouyang L, et al. Among authors: liu y, liu n, liu s. Signal Transduct Target Ther. 2020 Jun 17;5(1):78. doi: 10.1038/s41392-020-0181-3. Signal Transduct Target Ther. 2020. PMID: 32546741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208,629 results

Search Page

Filters